Many studies have shown that alternative splicing and mutations in CDKN3 are related to the cellular immune microenvironment in liver cancer, and experiments conducted by Huang et al. showed that high expression of CDKN3 can be triggered by Tfh cell-derived signals, an epigenetic mechanism regulating activated B cells [11]. Here, CDKN3 is linked to liver cancer.